17 Results for "

eEF2K

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "eEF2K" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
9
9 Publications Verification
Referencia número: HY-110096
No. CAS: 142557-61-7
Pureza:  99.34%
Target:  

CaMK Autophagy

Áreas de investigación:  

Cancer

A-484954 is a highly selective eukaryotic elongationfactor-2 kinase(eEF2K) inhibitor, with an IC50 of 280 nM.
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-100576
No. CAS: 278603-08-0
Pureza:  99.63%
Áreas de investigación:  

Infection Cancer

NH125 is a potent and selective inhibitor of eukaryotic elongation factor 2 kinase (eEF-2K/CaMKIII) with an IC50 of 60 nM for eEF-2K. NH125 kills methicillin-resistant S. aureus (MRSA) persisters by interacting with and disrupting membranes [2].
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P701676
Pureza:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: eEF2K; Eukaryotic elongation factor 2 kinase; eEF-2 kinase; eEF-2K; Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase
Species:  
Source:  
loading...
    loading...
Referencia número: HY-146324
No. CAS: 2458170-54-0
Pureza:  98.64%
Target:  

PROTACs Apoptosis CaMK

Áreas de investigación:  

Cancer

PROTAC eEF2K degrader-1 (Compound 11l) is an eEF2K-Targeting PROTAC small molecule that induces apoptosis in MDA-MB-231 cells. PROTAC eEF2K degrader-1 mediates eEF2K degradation .
loading...
    loading...
Referencia número: HY-177720
No. CAS: 1044797-96-7
Áreas de investigación:  

Cancer

eEF2K degrader-2 (Compound C1) is a molecular glucose degrading agent that targets the eEF2K protein. eEF2K degrader-2 can significantly inhibit the proliferation, migration, invasion and induce apoptosis of triple negative breast cancer (TNBC) cells. eEF2K degrader-2 has no obvious organ toxicity or pathological damage. eEF2K degrader-2 can be used in the research of cancer such as breast cancer .
loading...
    loading...
Referencia número: HY-RS04181
Áreas de investigación:  

Others

EEF2K Human Pre-designed siRNA Set A contains three designed siRNAs for EEF2K gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-RS26516
Áreas de investigación:  

Others

Eef2k Rat Pre-designed siRNA Set A contains three designed siRNAs for Eef2k gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-RS20013
Áreas de investigación:  

Others

Eef2k Mouse Pre-designed siRNA Set A contains three designed siRNAs for Eef2k gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-184950
No. CAS: 2458170-55-1
Áreas de investigación:  

Cancer

eEF2K ligand-1 is a PROTAC target protein ligand that targets eEF2K, and it is applicable to research related to PROTAC synthesis. eEF2K ligand-1 serves as the target protein of PROTAC eEF2K degrader-1 (HY-146324) .
loading...
    loading...
Referencia número: HY-123024
No. CAS: 51627-14-6
Synonyms: BL-S-640; SK&F 60771
Áreas de investigación:  

Infection Cancer

Cefatrizine (BL-S-640) is an orally active and broad-spectrum cephalosporin antibiotic. Cefatrizine is also a eEF2K inhibitor, with anti-proliferative activity in human breast cancer cells, which could induce ER stress, leading to cell death. Cefatrizine can be used in studies of cancer and bacterial infection [2].
loading...
    loading...
Referencia número: HY-112393
No. CAS: 503473-32-3
Target:  

HIV Src PKA PKC

Áreas de investigación:  

Infection

TX-1918 is an inhibitor for eukaryotic elongation factor 2 kinase (eEF2-K) and Src kinase with IC50 of 0.44 and 4.4 μM, respectively. TX-1918 exhibits cytotoxicity in cell HepG2 and HCT116, with IC50 of 2.07 and 230 μM, respectively. TX-1918 inhibits the C-terminal domain of HIV-1 CA (CA CTD)(IC50 =3.81 μM), and inhibits the viral replication (IC50 =15.16 μM) [2].
loading...
    loading...
Referencia número: HY-121828
No. CAS: 157397-06-3
Target:  

Src CaMK PKA EGFR PKC COX

Áreas de investigación:  

Cancer

TX-1123 is a potent protein tyrosine kinase (PTK) inhibitor for Src, eEF2-K, and PKA, and EGFR-K/PKC. TX-1123 is a cyclo-oxygenase (COX) inhibitor with IC50 values of 1.16 μM and 15.7 μM for COX2 and COX1, respectively. TX-1123 has low mitochondrial toxicity. TX-1123 can be used in research of cancer [2].
loading...
    loading...
Referencia número: HY-181506
No. CAS: 3109321-90-3
Áreas de investigación:  

Cancer

TYMJ-01 is a fluorescent probe and eEF2K degrader. TYMJ-01 induces dose-dependent and specific degradation of eEF2K via the ubiquitin-proteasome pathway, with a DC50 of 82 nM. TYMJ-01 inhibits the proliferation, migration and invasion of triple-negative breast cancer cells. TYMJ-01 enables dynamic fluorescent imaging of eEF2K degradation in triple-negative breast cancer cells; it enhances the anti-tumor activity of Paclitaxel (HY-B0015). TYMJ-01 can be used for the research of triple-negative breast cancer .
loading...
    loading...
Referencia número: HY-P811094
Synonyms: Eukaryotic elongation factor 2 kinase, eEF-2 kinase, eEF-2K, Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase, eEF2K

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Rat, Monkey

loading...
    loading...
Referencia número: HY-176149
Áreas de investigación:  

Cancer

Fluoxetine-Conjugated Platinum(IV) prodrug-1 (Compound 8) is an eEF2K inhibitor. Fluoxetine-Conjugated Platinum(IV) prodrug-1 inhibits cancer cell proliferation, induces DNA damage, cell cycle arrest at S phase and apoptosis. Fluoxetine-Conjugated Platinum(IV) prodrug-1 induces ROS accumulation and mitochondrial dysfunction. Fluoxetine-Conjugated Platinum(IV) prodrug-1 inhibits TNBC cell migration and invasion by inhibiting MMP-2 activity. Fluoxetine-Conjugated Platinum(IV) prodrug-1 induces autophagy in TNBC cells by activating AMPK. Fluoxetine-Conjugated Platinum(IV) prodrug-1 has antitumor activity and activates immunosuppression in the 4T1-Luc mouse model. Fluoxetine-Conjugated Platinum(IV) prodrug-1 can be used in triple-negative breast cancer (TNBC) research .
loading...
    loading...
Referencia número: HY-P811035
Synonyms: Eukaryotic elongation factor 2 kinase, eEF-2 kinase, eEF-2K, Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase, eEF2K

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Rat, Monkey

loading...
    loading...
Referencia número: HY-P86858
Synonyms: C86191 antibody; Calcium/calmodulin dependent eukaryotic elongation factor 2 antibody; Calcium/calmodulin dependent eukaryotic elongation factor 2 kinase antibody; Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase antibody; Calmodulin dependent protein kinase III antibody; cb365 antibody; EC 2.7.11.20 antibody; eEF 2 kinase antibody; eEF 2K antibody; eEF-2 kinase antibody; C86191 antibody; Calcium/calmodulin dependent eukaryotic elongation factor 2 antibody; Calcium/calmodulin dependent eukaryotic elongation factor 2 kinase antibody; Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase antibody; Calmodulin dependent protein kinase III antibody; cb365 antibody; EC 2.7.11.20 antibody; eEF 2 kinase antibody; eEF 2K antibody; eEF-2 kinase antibody; eEF-2K antibody; eEF2K antibody; eEF2K protein antibody; EF2K_HUMAN antibody; Elongation factor 2 kinase antibody; Eukaryotic elongation factor 2 kinase antibody; fa04b08 antibody; HSU93850 antibody; kinase eEF2K antibody; MGC45041 antibody; SMEF2K antibody; wu:fa04b08 antibody; zgc:100973 antibody;

Host:  

Rabbit

Application:  

WB, ICC/IF, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
  • 1